We are live on ! Find out more
DARE icon

Dare Bioscience
DARE

36 hedge funds and large institutions have $9.12M invested in Dare Bioscience in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 17 increasing their positions, 5 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

240% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 5

0.01% more ownership

Funds ownership: 0.72% → 0.73% (+0.01%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

8% less capital invested

Capital invested by funds: $9.89M → $9.12M (-$768K)

10% less funds holding

Funds holding: 40 → 36 (-4)

44% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 9

Holders
36
Holders Change
-4
Holders Change %
-10%
% of All Funds
0.61%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
17
Reduced
5
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$334K
2
SAM
Soviero Asset Management
New York
+$251K
3
Millennium Management
Millennium Management
New York
+$237K
4
BlackRock
BlackRock
New York
+$140K
5
FFS
Founders Financial Securities
Maryland
+$130K

Top Sellers

Rank Fund Capital Flow
1
GCP
GSA Capital Partners
United Kingdom
-$117K
2
Marshall Wace
Marshall Wace
United Kingdom
-$110K
3
ECM
ExodusPoint Capital Management
New York
-$108K
4
Jane Street
Jane Street
New York
-$87K
5
Citadel Advisors
Citadel Advisors
Florida
-$63K
Name Holding Trade Value Shares
Change 		Change in
Stake
UCFA
26
United Capital Financial Advisors
Texas
$19K +$1.01K +67 +5%
Victory Capital Management
27
Victory Capital Management
Texas
$14K -$196 -13 -1%
IA
28
IFS Advisors
Kansas
$14K – – –
Susquehanna International Group
29
Susquehanna International Group
Pennsylvania
$13K +$13K +867 New
PNC Financial Services Group
30
PNC Financial Services Group
Pennsylvania
$4K +$1.25K +83 +42%
Wells Fargo
31
Wells Fargo
California
$3K +$120 +8 +4%
Morgan Stanley
32
Morgan Stanley
New York
$3K +$3.15K +209 +1,742%
APA
33
American Portfolios Advisors
New York
$1.23K – – –
AWA
34
Artemis Wealth Advisors
New York
$1.08K – – –
UBS Group
35
UBS Group
Switzerland
$1K -$5.97K -397 -90%
HNWAG
36
High Net Worth Advisory Group
Florida
$1K – – –
Marshall Wace
37
Marshall Wace
United Kingdom
– -$110K -6,140 Closed
ECM
38
ExodusPoint Capital Management
New York
– -$108K -6,055 Closed
Jane Street
39
Jane Street
New York
– -$87K -4,884 Closed
Citadel Advisors
40
Citadel Advisors
Florida
– -$63K -3,532 Closed
FPAS
41
Focus Partners Advisor Solutions
Missouri
– -$45K -2,500 Closed
Bank of America
42
Bank of America
North Carolina
– -$44K -2,473 Closed
Citigroup
43
Citigroup
New York
– -$40K -2,212 Closed
Squarepoint
44
Squarepoint
New York
– -$17K -968 Closed
TIM
45
Tortoise Investment Management
New York
– -$1K -63 Closed
1
2

DARE Hedge Fund Activity: Q2 2022 in Review

36 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q2 2022, worth a combined $9.12M — down 7.8% from $9.89M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of DARE and 5 opened new positions — a net loss of 4 holders — while 5 trimmed existing stakes and 17 added.

The largest buyer was Renaissance Technologies, adding an estimated $334K. The largest seller was GSA Capital Partners, cutting an estimated $117K.

  • 36 institutional investors held Dare Bioscience (DARE) as of Q2 2022, down from 40 in Q1 2022.
  • Funds reported $9.12M of Dare Bioscience stock for Q2 2022, down 7.8% quarter-over-quarter.
  • 5 funds opened new Dare Bioscience positions in Q2 2022 and 9 closed out, a net change of -4 holders.
  • The largest Dare Bioscience buyer in Q2 2022 was Renaissance Technologies, an estimated $334K added.
  • The largest Dare Bioscience seller in Q2 2022 was GSA Capital Partners, an estimated $117K sold.

Based on aggregated 13F filings for Q2 2022.